immagine

Attività svolta

Desidero ricevere una copia cartacea
Informativa sulla privacy
Iscrizione alla newsletter

Trattamento delle pancreatiti acute e croniche nel gatto

Bibliografia

 

1. Armstrong PJ, Williams DA. Pancreatitis in cats. Top. Companion Anim. Med. 2012;27(3):140­147.

2. Bang UC, Semb S, Nojgaard C et coll. Pharmacological approach to acute pancreatitis. World J. Gastroenterol. 2008;14(19):2968­2976.

3. Büchler MW, Gloor B, Müller CA et coll. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann. Surg. 2000;232(5):619­626.

4. Buxbaum JL, Quezada M, Da B et coll. Early aggressive hydration hastens clinical improvement in mild acute pancreatitis. Am. J. Gastroenterol. 2017;112(5):797­803.

5. Černá P, Kilpatrick S, Gunn­Moore DA. Feline comorbidities: what do we really know about feline triaditis? J. Feline Med. Surg. 2020;22(11):1047­1067.

6. De Cock HEV, Forman MA, Farver TB et coll. Prevalence and histopathologic characteristics of pancreatitis in cats. Vet. Pathol. 2007;44:39­49.

7. Dong LH, Liu ZM, Wang SJ et coll. Corticosteroid therapy for severe acute pancreatitis: a meta­analysis of randomized, controlled trials. Int. J. Clin. Exp. Pathol. 2015;8(7):7654­7660.

8. Enomoto M, Mantyh PW, Murrell J et coll. Anti­nerve growth factor monoclonal antibodies for the control of pain in dogs and cats. Vet. Rec. 2019;184(1):23. 9. Forman MA, Steiner JM, Armstrong PJ et coll. ACVIM consensus statement on pancreatitis in cats. J. Vet. Intern. Med. 2021;35(2):703­723.

10. Frick TW, Spycher MA, Heitz PU et coll. Hypercalcaemia and pancreatic ultrastructure in cats. Eur. J. Surg. 1992;158(5):289­294.

11. Guedes AGP, Meadows JM, Pypendop BH et coll. Evaluation of tramadol for treatment of osteoarthritis in geriatric cats. J. Am. Vet. Med. Assoc. 2018;252(5):565­571. 1

2. Guedes AGP, Meadows JM, Pypendop BH et coll. Assessment of the effects of gabapentin on activity levels and owner­perceived mobility impairment and quality of life in osteoarthritic geriatric cats. J. Am. Vet. Med. Assoc. 2018;253(5):579­585.

13. Hickman MA, Cox SR, Mahabir S et coll. Safety, pharmacokinetics and use of the novel NK­1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats. J. Vet. Pharmacol. Ther. 2008;31(3):220­229.

14. Husnik R, Gaschen FP, Fletcher JM et coll. Ultrasonographic assessment of the effect of metoclopramide, erythromycin, and exenatide on solid­phase gastric emptying in healthy cats. J. Vet. Intern. Med. 2020;34(4):1440­1446.

15. Jensen KB, Chan DL. Nutritional management of acute pancreatitis in dogs and cats. J. Vet. Emerg. Crit. Care (San Antonio). 2014;24(3):240­250.

16. Karanjia ND, Lutrin FJ, Chang YB et coll. Low dose dopamine protects against hemorrhagic pancreatitis in cats. J. Surg. Res. 1990;48(5):440­443.

17. Kimmel SE, Washabau RJ, Drobatz KJ. Incidence and prognostic value of low plasma ionized calcium concentration in cats with acute pancreatitis: 46 cases (1996­1998). J. Am. Vet. Med. Assoc. 2001;219(8):1105­1109.

18. Klaus JA, Rudloff E, Kirby R. Nasogastric tube feeding in cats with suspected acute pancreatitis: 55 cases (2001­2006). J. Vet. Emerg. Crit. Care (San Antonio). 2009;19(4):337­346.

19. Lukman Hoeyrup N, Spillmann T, Toresson L et coll. Effects of cyclosporine treatment on supranormal feline serum pancreatic lipase immunoreactivity concentrations. Poster ECVIM 2020, Research communications, 30th ECVIM­CA online congress. J. Vet. Intern. Med. 2020;34:3058­3166.

20. Mirtallo JM, Forbes A, McClave SA et coll. International consensus guidelines for nutrition therapy in pancreatitis. J. Parenter. Enteral. Nutr. 2012;36(3):284­291.

21. Nivy R, Kaplanov A, Kuzi S et coll. A retrospective study of 157 hospitalized cats with pancreatitis in a tertiary care center: clinical, imaging and laboratory findings, potential prognostic markers and outcome. J. Vet. Intern. Med. 2018;32(6):1874­1885.

22. Niyom S, Boscan P, Twedt DC et coll. Effect of maropitant, a neurokinin­1 receptor antagonist, on the minimum alveolar concentration of sevoflurane during stimulation of the ovarian ligament in cats. Vet. Anaesth. Analg. 2013;40(4):425­431.

23. Okanishi H, Nagata T, Nakane S et coll. Comparison of initial treatment with and without corticosteroids for suspected acute pancreatitis in dogs. J. Small Anim. Pract. 2019;60(5):298­304.

24. Petrov MS, Kukosh MV, Emelyanov NV. A randomized controlled trial of enteral versus parenteral feeding in patients with predicted severe acute pancreatitis shows a significant reduction in mortality and in infected pancreatic complications with total enteral nutrition. Dig. Surg. 2006;23(5­6):336­344 25. Poole M, Quimby JM, Hu T et coll. A double­blind, placebo­controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss. J. Vet. Pharmacol. Ther. 2019;42(2):179­188.

26. Quimby JM, Benson KK, Summers SC et coll. Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease. J. Feline Med. Surg. 2020;22(4):376­383.

27. Robertson SA. Managing pain in feline patients. Vet. Clin. North Am. Small Anim. Pract. 2008;38(6):1267­1290, vi.

28. Son TT, Thompson L, Serrano S et coll. Surgical intervention in the management of severe acute pancreatitis in cats: 8 cases (2003­2007). J. Vet. Emerg. Crit. Care (San Antonio). 2010;20(4):426­435.

29. Steiner JM, Teague SR, Lees GE et coll. Stability of canine pancreatic lipase immunoreactivity concentration in serum samples and effects of long­term administration of prednisone to dogs on serum canine pancreatic lipase immunoreactivity concentrations. Am. J. Vet. Res. 2009;70(8):1001­1005.

30. Stockhaus C, Teske E, Schellenberger K et coll. Serial serum feline pancreatic lipase immunoreactivity concentrations and prognostic variables in 33 cats with pancreatitis. J. Am. Vet. Med. Assoc. 2013;243(12):1713­1718.

31. Schwaiger T, van den Brandt C, Fitzner B et coll. Autoimmune pancreatitis in MRL/Mp mice is a T cell­mediated disease responsive to cyclosporine A and rapamycin treatment. Gut. 2014;63(3):494­505.

32. Törner K, Aupperle­Lellbach H, Staudacher A et coll. Primary solid and cystic tumours of the exocrine pancreas in cats. J. Comp. Pathol. 2019;169:5­19. 33. Tsukamoto A, Ohgoda M, Haruki N et coll. The anti­inflammatory action of maropitant in a mouse model of acute pancreatitis. J. Vet. Med. Sci. 2018;80(3):492­498.

34. Twedt DC, Cullen J, McCord K et coll. Evaluation of fluorescence in situ hybridization for the detection of bacteria in feline inflammatory liver disease. J. Feline Med. Surg. 2014;16(2):109­117.

35. Zimmermann E, Hittmair KM, Suchodolski JS et coll. Serum felinespecific pancreatic lipase immunoreactivity concentrations and abdominal ultrasonographic findings in cats with trauma resulting from high­rise syndrome. J. Am. Vet. Med. Assoc. 2013;242(9):1238­1243.

TORNA INDIETRO
Abbonati per accedere

Dal web internazionale
10/12/2024

Patologia comparata del tumore alla prostata del cane e dell'uomo

Sebbene relativamente raro nei cani, il cancro alla prostata (PCa) è il tumore non cutaneo più comune negli uomini. Le ghiandole prostatiche umane e canine condividono molte caratteristiche funzionali, anatomiche e fisiologiche. A causa di queste somiglianze, il PCa canino è stato proposto come modello per il PCa negli uomini.

 
 
Formazione a distanza abbinata a SUMMA

SPC-sviluppo-professionale-continuo